Case Files from the Lipid Clinic

Epidemiological studies and controlled clinical trials testify to the benefits and safety of lipid-modifying therapy. Nevertheless, a small but significant proportion of patients will experience adverse events when using lipid-modifying drugs, others will not reach goal lipid levels, others do not continue with their medication! This presentation will address a number of practical, real-life scenarios and how they were managed.

A/Prof Leon Simons 

Supported by Astra Zeneca